Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

At the end of April the Court of Justice of the European Union (CJEU) delivered its judgment in Case C-650/17 Royalty Pharma Collection Trust.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More on this story

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More on this story

Americas

Will the EU’s SPC manufacturing waiver weaken European pharma’s IP?

20 May 2020 Despite dire warnings by the US Chamber of Commerce, the impact of the EU’s SPC waiver won’t be known for years, says Paul Williams of Lewis Silkin.

Europe

Unitary SPC should follow new patent system: EC official

11 June 2020 The European Commission wants to implement a unitary supplementary protection certificate, its top IP official has said.

Big Pharma

UKIPO cancels SPC extension at owner’s request

16 June 2020 The UK Intellectual Property Office has agreed to revoke an extension to a supplementary protection certificate for immunosuppressant tocilizumab, at the request of the owners.

More features

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

GSK triumphs in EPO appeal, revoking Pfizer patent

Herbert Smith Freehills and Kramer Levin in $2bn merger talks

Teva fights for re-listing of inhaler patents at US appeals court

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

Sandoz lands reduced antitrust award of $70m

Royalty Pharma: welcome clarity mixed with unwelcome ambiguity

More on this story

Editor's picks

Editor's picks

More on this story

More on this story

More features